Science & Enterprise subscription

Follow us on Twitter

  • An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals li… https://t.co/AqWMpFYG5Q
    about 15 hours ago
  • New post on Science and Enterprise: Synthetic DNA Studied for Mass Data Storage https://t.co/XeKsILkGR0 #Science #Business
    about 15 hours ago
  • Engineers developed a more sustainable type of concrete adding a form of bacteria to grow and reproduce the materia… https://t.co/7naaOf9CYF
    about 19 hours ago
  • New post on Science and Enterprise: Living, Reproducing Concrete Created with Bacteria https://t.co/1RWPEfpvmz #Science #Business
    about 19 hours ago
  • Smart money? The US company receiving the most venture capital money through 2019 is e-cigarette maker Juul Labs, a… https://t.co/YHMyj4Aavo
    about 2 days ago

Please share Science & Enterprise

Commentary – New Models Needed for Antibiotic Resistance

MRSA bacteria

Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge. . . . → Read More: Commentary – New Models Needed for Antibiotic Resistance

FDA Chief Calls Teen Vaping an “Epidemic”

Scott Gottlieb at Brookings Institution

The commissioner of the Food and Drug Administration warned that the sharp rise in teen electronic cigarette use is an epidemic threatening the public health. . . . → Read More: FDA Chief Calls Teen Vaping an “Epidemic”

Insulin Delivered by Capsule, That’s the Good News

Diabetes word cloud

Before we start celebrating the end of injections, we need to deal with a more basic problem facing people with diabetes, namely the rapidly rising cost of insulin. . . . → Read More: Insulin Delivered by Capsule, That’s the Good News

Book Review – The Fifth Risk

The Fifth Risk cover

Michael Lewis describes in a gripping narrative some of those critical life-protecting functions the federal government performs in his new book The Fifth Risk. . . . → Read More: Book Review – The Fifth Risk

Personalized Breast Cancer Trial Advances 7 Drugs

Laura Esserman

A clinical trial with a design that allows for changes in its processes to meet the needs of individual patients says its results helped advance 7 new drugs for breast cancer into review by FDA. . . . → Read More: Personalized Breast Cancer Trial Advances 7 Drugs

You Call That a Drug Pricing Policy?

Pills on money

Although he called it, “the most sweeping action in history to lower the price of prescription drugs for the American people,” the plan was anything but that. . . . → Read More: You Call That a Drug Pricing Policy?

Drug Price Report Calls for Govt Negotiation, More Generics

A panel convened by the National Academies calls for the federal government to use its buying power to negotiate better drug prices for consumers. . . . → Read More: Drug Price Report Calls for Govt Negotiation, More Generics

Here’s What a Real Opioid Emergency Looks Like

Let’s be clear — the limited steps ordered by the president to reduce the numbers of people addicted to opioids don’t look anything like a response to an emergency. . . . → Read More: Here’s What a Real Opioid Emergency Looks Like

Flashback: Drug Pricing Reform Even Big Pharma Might Like

Science & Enterprise is taking a break From 2 to 13 October. Until then, we will re-run some of our recent special reports. Our regular posts will return on 16 October.

(TBIT/Pixabay)

2 May 2016. At a press event in Washington, D.C. last week, Representative Lloyd Doggett of Texas, a champion of lower . . . → Read More: Flashback: Drug Pricing Reform Even Big Pharma Might Like

Immigration Crackdown “a Disaster” for U.S. Science

A panel of research executives from American universities said the current hostility to immigration in the U.S. is causing fear among many researchers and could have a serious impact on science. . . . → Read More: Immigration Crackdown “a Disaster” for U.S. Science